EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Impact of Early Subcutaneous Basal Insulin With Intravenous Insulin Infusion for Diabetic Ketoacidosis and Glycaemic Outcomes: A Systematic Review and Meta‐Analysis

Abdallah AbuJlambo iD, Maha AbuZarifa iD, Rejean R R Sawh, Subhash Reddy Narayana Reddy N, Muhammad Bin Salman iD, Insiya Mohammed Rampurawala, Yara Ashour iD, Hazem Ayesh iD

Endocrinology, Diabetes & Metabolism · 2026

DOI: 10.1002/edm2.70277 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2026. Verfasst von Abdallah AbuJlambo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of ICU, Al-Shifa Hospital, Gaza, Palestine. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic ketoacidosis (DKA) is a life‐threatening metabolic emergency requiring prompt insulin therapy. Although intravenous (IV) insulin infusion remains the standard treatment, early initiation of subcutaneous (SC) basal insulin during IV therapy may improve outcomes. We evaluated the efficacy and safety of early basal insulin administration in adults with DKA.

Methods

A systematic review and meta‐analysis following PRISMA 2020 guidelines searched PubMed, Embase and Cochrane Library from inception to February 2026 for randomised controlled trials (RCTs) comparing early SC basal insulin plus IV insulin versus IV insulin alone in adults with DKA. Primary outcomes were time to DKA resolution and hospital length of stay. Secondary outcomes included total fluid requirement, hypoglycaemia, rebound hyperglycaemia, recurrent DKA, electrolyte disturbances and mortality. Meta‐regression explored sources of heterogeneity.

Results

Eight RCTs involving 407 participants were included. Early basal insulin significantly reduced time to DKA resolution (MD −4.06 h, 95% CI −5.53 to −2.58; p < 0.0001; I 2 = 56.3%), with consistent findings in sensitivity analysis (MD −3.44 h; I 2 = 0%). Total fluid requirements decreased by approximately 400 mL, although clinical significance was modest. No significant differences were observed in hospital length of stay, rebound hyperglycaemia, recurrent DKA, hypoglycaemia, hypokalaemia, or mortality. Meta‐regression showed no significant effect modification by age, BMI, sample size, or male proportion.

Conclusions

Early SC basal insulin combined with IV insulin significantly shortens DKA resolution time and modestly reduces fluid requirements without increasing adverse events. While no significant effects were observed on hospital stay or recurrence outcomes, these findings support the safety and potential clinical benefit of early basal insulin use in DKA management. Larger multicentre trials are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic KetoacidosisInsulinHypoglycemic AgentsHumansInfusions, IntravenousBlood GlucoseTreatment OutcomeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

basal insulindiabetic ketoacidosisglycaemic controlintravenous insulinmeta‐analysisrandomised controlled trials

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Department of ICU, Al-Shifa Hospital, Gaza, Palestine.
  • Al-Azhar Branch, Al-Quds University, Gaza, Palestine.
  • UCHealth Parkview Medical Center, Pueblo, Colorado, USA.
  • Department of Public Health, Bruhat Bengaluru Mahanagara Palike (BBMP), Karnataka, India.
  • Department of Internal Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
  • JSS Medical College, Mysore, India.

ORCID-Profile: Abdallah AbuJlambo, Maha AbuZarifa, Muhammad Bin Salman, Yara Ashour, Hazem Ayesh

Zitieren

APA

AbuJlambo, A., AbuZarifa, M., Sawh, R. R. R., Narayana Reddy N, S. R., Salman, M. B., Rampurawala, I. M., Ashour, Y., & Ayesh, H. (2026). Impact of Early Subcutaneous Basal Insulin With Intravenous Insulin Infusion for Diabetic Ketoacidosis and Glycaemic Outcomes: A Systematic Review and Meta‐Analysis. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70277

Vancouver

AbuJlambo A, AbuZarifa M, Sawh RRR, Narayana Reddy N SR, Salman MB, Rampurawala IM, et al. Impact of Early Subcutaneous Basal Insulin With Intravenous Insulin Infusion for Diabetic Ketoacidosis and Glycaemic Outcomes: A Systematic Review and Meta‐Analysis. Endocrinology, Diabetes & Metabolism. 2026. doi:10.1002/edm2.70277

BibTeX
@article{AbuJlambo2026,
  author = {AbuJlambo, Abdallah and AbuZarifa, Maha and Sawh, Rejean R R and Narayana Reddy N, Subhash Reddy and Salman, Muhammad Bin and Rampurawala, Insiya Mohammed and Ashour, Yara and Ayesh, Hazem},
  title = {Impact of Early Subcutaneous Basal Insulin With Intravenous Insulin Infusion for Diabetic Ketoacidosis and Glycaemic Outcomes: A Systematic Review and Meta‐Analysis},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  doi = {10.1002/edm2.70277}
}
Kostenlos starten →